Lung cancer risk and variation in MGMT activity and sequence

DNA Repair

Volumn 6, Issue 8, 2007, Pages 1134-1144

  Povey, Andrew C ^a   Margison, Geoffrey P ^b   Santibáñez Koref, Mauro F ^c  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b CHRISTIE HOSPITAL   (United Kingdom)

^c NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Lung cancer; MGMT; O6 Alkylguanine; Smoking

Indexed keywords

6 O ALKYLGUANINE DNA ALKYLTRANSFERASE; 7 METHYLGUANINE; DACARBAZINE; GUANINE;

ALLELE; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CASE CONTROL STUDY; DNA ALKYLATION; DNA DAMAGE; DNA POLYMORPHISM; DNA REPAIR; FIBROBLAST; GENE ACTIVITY; GENE EXPRESSION; GENE SEQUENCE; GENOTYPE; HUMAN; LUNG ADENOCARCINOMA; LUNG PARENCHYMA; LYMPHOCYTE; NONHUMAN; PRIORITY JOURNAL; THYROID CANCER;

ALKYLATING AGENTS; ANIMALS; DNA DAMAGE; DNA MODIFICATION METHYLASES; DNA REPAIR ENZYMES; GUANINE; HUMANS; LUNG; LUNG NEOPLASMS; POLYMORPHISM, GENETIC; RISK FACTORS; TUMOR SUPPRESSOR PROTEINS; VARIATION (GENETICS);

ANIMALIA; NICOTIANA TABACUM;

EID: 34447327215     PISSN: 15687864     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dnarep.2007.03.022     Document Type: Article

References (85)

1. 6-alkylguanine by alkyltransferases. Mutat. Res. 462 (2000) 83-100
2. 6-Alkylguanine-DNA alkyltransferase: role in carcinogenesis and chemotherapy. BioEssays 24 (2002) 255-266
3. Gerson S.L. MGMT: its role in cancer aetiology and cancer therapeutics. Nat. Rev. Cancer 4 (2004) 296-307
4. Kaina B., and Christmann M. DNA repair in resistance to alkylating anticancer drugs. Int. J. Clin. Pharm. Ther. 40 (2002) 354-367
5. 6-alkylguanine-DNA alkyltransferase activity. Carcinogenesis 24 (2003) 625-635
6. Kawate H., Sakumi K., Tsuzuki T., Nakatsuro Y., Ishikawa T., Takahashi S., Takano H., Noda T., and Sekiguchi M. Separation of killing and tumorigenic effects of an alkylating agent in mice defective in two of the DNA repair genes. Proc. Natl. Acad. Sci. U.S.A. 95 (1998) 5116-5120
7. 6-n-butyldeoxyguanosine in human cells. Carcinogenesis 7 (1986) 1987-1990
8. 6-methylguanine-DNA methyltransferase is a negative regulator of estrogen receptor-mediated transcription upon alkylation DNA damage. Mol. Cell. Biol. 21 (2001) 7105-7114
9. 6-alkylguanine-DNA alkyltransferases are hypersensitive to dibromoalkanes. Chem. Res. Toxicol. 12 (1999) 544-551
10. 6-alkylguanine-DNA alkyltransferase. J. Biol. Chem. 277 (2002) 37920-37928
11. Shiraishi A., Sakumi K., and Sekiguchi M. Increased susceptibility to chemotherapeutic alkylating agents of mice deficient in DNA repair methyltransferase. Carcinogenesis 21 (2000) 1879-1883
12. Sakumi K., Shiraishi A., Shimizu S., Tsuzuki T., Ishikawa T., and Sekiguchi M. Methylnitrosourea-induced tumorigenesis in MGMT gene knockout mice. Cancer Res. 57 (1997) 2415-2418
13. Iwakuma T., Sakumi K., Nakatsuru Y., Kawate H., Igarashi H., Shiraishi A., Tsuzuki T., Ishikawa T., and Sekiguchi M. High incidence of nitrosamine-induced tumorigenesis in mice lacking DNA repair methyltransferase. Carcinogenesis 18 (1997) 1631-1635
14. 6-alkylguanine-DNA alkyltransferase. Science 259 (1993) 219-222
15. 6-methylguanine-DNA methyltransferase (MGMT) in transgenic mice protects against tumor initiation in two-stage skin carcinogenesis. Cancer Res. 56 (1996) 3244-3249
16. Liu L., Qin X., and Gerson S.L. Reduced lung tumorigenesis in human methylguanine DNA-methyltransferase transgenic mice achieved by expression of transgene within the target cells. Carcinogenesis 20 (1999) 279-284
17. Kawate H., Itoh R., Sakumi K., Nakabeppu Y., Tsuzuki T., Ide F., Ishikawa T., Noda T., Nawata H., and Sekiguchi M. A defect in a single allele of the mlh1 gene causes dissociation of the killing and tumorigenic actions of an alkylating carcinogen in methyltransferase-deficient mice. Carcinogenesis 21 (2000) 301-305
18. Hecht S.S. Tobacco carcinogens, their biomarkers and tobacco-induced cancer. Nat. Rev. Cancer 3 (2003) 733-744
19. Hecht S.S. DNA adduct formation from tobacco-specific N-nitrosamines. Mutat. Res. 424 (1999) 127-142
20. Hecht S.S., Jordan K.G., Choi C.-I., and Trushin N. Effects of deuterium substitution on the tumorigenicity of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol in A/J mice. Carcinogenesis 11 (1990) 1017-1020
21. 6-methylguanine formation in Clara cells and induction of pulmonary neoplasia in the rat by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. Cancer Res. 50 (1990) 3772-3780
22. Carmella S.G., Akerkar S.A., Richie Jr. J.P., and Hecht S.S. Intra-individual and inter-individual differences in metabolites of the tobacco-specific lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in Smokers' urine. Cancer Epidemiol. Biomarkers Prev. 4 (1995) 635-642
23. 6-Methylguanine DNA adducts associated with occupational nitrosamine exposure. Carcinogenesis 21 (2000) 29-33
24. Forman D. Dietary exposure to N-nitroso compounds and the risk of human cancer. Cancer Surv. 6 (1987) 719-738
25. 6-Methylguanine formation, repair protein depletion and clinical outcome with a 4 h schedule of temozolomide in the treatment of advanced melanoma: results of a phase II study. Int. J. Cancer 88 (2000) 469-473
26. Bellander T., Osterdahl B.G., and Hagmar L. Formation of N-mononitrosopiperazine in the stomach and its excretion in the urine after oral intake of piperazine. Toxicol. Appl. Pharmacol. 80 (1985) 193-198
27. 6-methylguanine in DNA. Cancer Res. 57 (1997) 366-369
28. 6-alkylguanine-DNA alkyltransferase deficient cells. Carcinogenesis 18 (1997) 1561-1567
29. Rydberg B., and Lindahl T. Nonenzymatic methylation of DNA by the intracellular methyl group donor S-adenosyl-l-methionine is a potentially mutagenic reaction. EMBO J. 1 (1982) 211-216
30. van Maanen J.M., Pachen D.M., Dallinga J.W., and Kleinjans J.C. Formation of nitrosamines during consumption of nitrate- and amine-rich foods, and the influence of the use of mouthwashes. Cancer Detect. Prev. 22 (1998) 204-212
31. Mostafa M.H., Helmi S., Badawi A.F., Tricker A.R., Spiegelhalder B., and Preussmann R. Nitrate, nitrite and volatile N-nitroso compounds in the urine of Schistosoma haematobium and Schistosoma mansoni infected patients. Carcinogenesis 15 (1994) 619-625
32. Povey A.C. DNA adducts: endogenous and induced. Toxicol. Pathol. 28 (2000) 405-414
33. Tricker A.R., Ditrich C., and Preussmann R. N-Nitroso compounds in cigarette tobacco and their occurrence in mainstream. Carcinogenesis 12 (1991) 257-261
34. Hecht S.S. Biochemistry, biology, and carcinogenicity of tobacco-specific N-nitrosamines. Chem. Res. Toxicol. 11 (1998) 559-603
35. Hecht S.S. Tobacco smoke carcinogens and lung cancer. J. Natl. Cancer Inst. 91 (1999) 1194-1210
36. Hoffmann D., Djordjevic M.V., and Hoffmann I. The changing cigarette. Prev. Med. 26 (1997) 427-434
37. Bianchini F., and Wild C.P. Comparison of 7-medG formation in white blood cells, liver and target organs in rats treated with methylating carcinogens. Carcinogenesis 15 (1994) 1137-1141
38. 32P-postlabeling assay of N7-methyldeoxyguanosine. Cancer Res. 50 (1990) 6580-6584
39. 32P-postlabelling assay. Carcinogenesis 14 (1993) 545-550
40. Kato S., Bowman E.D., Harrington A.M., Blomeke B., and Shields P.G. Human lung carcinogen-DNA adduct levels mediated by genetic polymorphisms in vivo. J. Natl. Cancer Inst. 87 (1995) 902-907
41. Blomeke B., Greenblatt M.J., Doan V.D., Bowman E.D., Murphy S.E., Chen C.C., Kato S., and Shields P.G. Distribution of 7-alkyl-2′-deoxyguanosine adduct levels in human lung. Carcinogenesis 17 (1996) 741-748
42. 32P-postlabeling analysis of 7-methylguanine in human bronchial and lymphocyte DNA. Carcinogenesis 14 (1993) 151-154
43. Zhao C., Tyndyk M., Eide I., and Hemminki K. Endogenous and background DNA adducts by methylating and 2-hydroxyethylating agents. Mutat. Res. 424 (1999) 117-125
44. Petruzzelli S., Tavanti L.M., Celi A., and Giuntini C. Detection of N7-methyldeoxyguanosine adducts in human pulmonary alveolar cells. Am. J. Respir. Cell. Mol. Biol. 15 (1996) 216-223
45. Lewis S.J., Cherry N.M., McLNiven R., Barber P.V., and Povey A.C. Associations between smoking, GST genotypes and N7-methylguanine levels in DNA extracted from bronchial lavage cells. Mutat. Res. 559 (2004) 11-18
46. Wilson V.L., Weston A., Manchester D.K., Trivers G.E., Roberts D.W., Kadlubar F.F., Wild C.P., Montesano R., Willey J.C., Mann D.L., and Harris C.C. Alkyl and aryl carcinogen adducts detected in human peripheral lung. Carcinogenesis 10 (1989) 2149-2152
47. Beranek D.T. Distribution of methyl and ethyl adducts following alkylation with monofunctional alkylating agents. Mutat. Res. 231 (1990) 11-30
48. 6-methylguanine residues in genomic DNA and production of sister chromatid exchanges, mutations and lethal events in a Mer-human tumor cell line. Mutat. Res. 314 (1994) 99-113
49. Belinsky S.A., White C.M., Devereux T.R., Swenberg J.A., and Anderson M.W. Cell-selective alkylation of DNA in rat lung following low dose exposure to the tobacco specific carcinogen 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone. Cancer Res. 47 (1987) 1143-1148
50. 6-alkylguanine-DNA alkyltransferase activity based on cellular DNA content in human, rat and mouse tissues. Carcinogenesis 7 (1986) 745-749
51. 6-Alkylguanine-DNA alkyltransferase activity in normal human tissues and cells. Cancer Res. 44 (1984) 2855-2857
52. 6-alkylguanine-DNA alkyltransferase activity in human lung. Carcinogenesis 15 (1994) 1535-1539
53. 6-Methylguanine-DNA methyltransferase activity in the human lung persists with advancing age. Gerontology 40 Suppl. 2 (1994) 3-9
54. 6-Methylguanine-DNA methyltransferase and uracil DNA glycosylase in human broncho-alveolar lavage cells and peripheral blood mononuclear cells from tobacco smokers and non-smokers. Carcinogenesis 12 (1991) 1389-1394
55. Janssen K., Eichhorn-Grombacher U., Schlink K., Nitzsche S., Oesch E., and Kaina B. Long-time expression of DNA repair enzymes MGMT and APE in human peripheral blood mononuclear cells. Arch. Toxicol. 75 (2001) 306-312
56. 6-alkylguanine-DNA alkyltransferase activity in circulating blood mononuclear cells of healthy human subjects. Int. J. Cancer 91 (2001) 60-66
57. 6-alkylguanine-DNA alkyltransferase expression in rat mammary epithelial cells. Cancer Lett. 75 (1993) 11-18
58. 6-alkylguanine-DNA alkyltransferase activity in bronchial epithelial cells. Int. J. Cancer 119 (2006) 463-466
59. 6-methylguanine-DNA methyltransferase gene linked to chromatin structure alteration. Carcinogenesis 24 (2003) 1337-1345
60. 6-methylguanine repair in fibroblast cultures from patients with lung cancer. Cancer Res. 49 (1989) 5623-5626
61. 6-Alkylguanine-DNA alkyltransferase activity in peripheral leukocytes, smoking and risk of lung cancer. Cancer Lett. 180 (2002) 33-39
62. 6-methylguanine DNA methyl transferase activities in patients with thyroid papillary carcinoma. Cancer Invest. 20 (2002) 965-971
63. Lees N.P., Harrison K.L., Hall C.N., Margison G.P., and Povey A.C. Reduced MGMT activity in human colorectal adenomas is associated with K-ras GC-AT transition mutations in a population exposed to methylating agents. Carcinogenesis 25 (2004) 1243-1247
64. 6-methylguanine-DNA methyltransferase by promoter hypermethylation is associated with G to A mutations in K-ras in colorectal tumorigenesis. Cancer Res. 60 (2000) 2369-2371
65. 6-Methylguanine-DNA methyltransferase promoter hypermethylation shifts the p53 mutational spectrum in non-small lung cancer. Cancer Res. 61 (2001) 8113-8117
66. Margison G.P., Povery A.C., and Santibanez-Koref M.F. Genetic variation at the human MGMT locus and its biological consequences. Current Pharmacogenomics 4 (2006) 133-144
67. 6-methylguanine-DNA methyltransferase gene. Nucl. Acids Res. 19 (1991) 6163-6167
68. 6-alkylguanine-DNA alkyltransferase activity in peripheral blood mononuclear cells. Carcinogenesis 26 (2005) 1473-1480
69. 6-methylguanine-DNA methyltransferase gene in young patients with adult type cancers and functional assay. Carcinogenesis 16 (1995) 2441-2445
70. 6-benzylguanine. Cancer Res. 56 (1996) 5571-5575
71. 6-alkylguanine-DNA alkyltransferase variants. Chem. Res. Toxicol. 17 (2004) 424-434
72. 6-alkylguanine-DNA alkyltransferase gene in normal tissue and cancer. Clin. Cancer Res. 5 (1999) 209-213
73. 6-alkylguanine DNA alkyltransferase gene in lung cancer risk. Cancer Epidemiol. Biomarkers Prev. 9 (2000) 339-342
74. Inoue R., Abe M., Nakabeppu Y., Sekiguchi M., Mori T., and Suzuki T. Characterization of human polymorphic DNA repair methyltransferase. Pharmacogenetics 10 (2000) 59-66
75. 6-alkylguanine-DNA alkyltransferases. Cancer Res. 66 (2006) 4968-4974
76. 6-methylguanine-DNA methyltransferase (MGMT) and N-methylpurine-DNA glycosylase (MPG) in lung cancer patients from Poland. Hum. Mutat. 14 (1999) 269-270
77. 6-methylguanine-DNA methyltransferase SNPs: a frequency comparison of patients with familial melanoma and healthy individuals in Sweden. Hum. Mutat. 20 (2002) 408-409
78. Krzesniak M., Butkiewicz D., Samojedny A., Chorazy M., and Rusin M. Polymorphisms in TDG and MGMT genes-epidemiological and functional study in lung cancer patients from Poland. Ann. Hum. Genet. 68 (2004) 300-312
79. 6-alkylguanine-DNA alkyltransferase are expressed at different levels in normal human lung tissue. Carcinogenesis 24 (2003) 1691-1694
80. 6-methylguanine-DNA-methyltransferase (MGMT) gene increase human sensitivity to the genotoxic effects of the tobacco-specific nitrosamine carcinogen NNK. Pharmacogenet. Genomics 15 (2005) 571-578
81. 6-Alkylguanine alkyltransferase gene polymorphisms and the risk of primary lung cancer. Mol. Carcinogen. 45 (2006) 239-249
82. 6-alkylguanine-DNA alkyltransferase gene and lung cancer risk in non-smokers exposed to second-hand smoke. Cancer Epidemiol. Biomarkers Prev. 13 (2004) 320-323
83. 6-methylguanine-DNA methyltransferase-codon 178 genetic polymorphism. Lung Cancer 44 (2004) 281-286
84. 6-methylguanine DNA methyltransferase and endometrial cancer risk. Carcinogenesis 27 (2006) 2281-2285
85. 6-Methylguanine-DNA methyltransferase Leu84Phe and Ile143Val polymorphisms and risk of colorectal cancer in the nurses' health study and physicians' health study (United States). Cancer Causes Control 17 (2006) 721-731